PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago Blue Cap AG: Major shareholder PartnerFonds creates basis for further progress in the realization of the Blue Cap share package PartnerFonds AG i.L. plans share exchange offer with Blue Cap AG at fair value, progressing liquidation process. Stable shareholder base confirmed by anchor investors Blue Cap AG Liquidation Process Share Exchange Offer PartnerFonds AG Anchor Investors
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago ATOSS Software SE: Successful start to the year in the first quarter of 2025 with continuous double-digit growth ATOSS Software SE reports successful first quarter results for 2025 with 11% revenue growth driven by cloud and subscription services. Management forecasts around EUR 190 million revenue for 2025 Revenue Growth Cloud Services First Quarter ATOSS Software SE 2025 Forecast
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago SoftwareOne publishes agenda for ordinary Annual General Meeting SoftwareOne Holding AG publishes agenda for ordinary Annual General Meeting with proposals for dividend approval and new Chairman election. Meeting to be held on 16 May 2025 in Lucerne Annual General Meeting Dividend Switzerland SoftwareOne Chairman Election
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago Nordex Group enters 2025 on a strong footing with improved margins, positive free cash flow and confirmation of full year guidance Nordex Group posts solid financial performance in Q1 2025 with improved margins and positive free cash flow, aiming to achieve full year targets Financial Performance EBITDA Margin Free Cash Flow Nordex Group Q1 2025
REGULATED PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago Safran publie son chiffre d’affaires du 1er trimestre 2025 Safran publie un chiffre d'affaires en forte croissance au 1er trimestre 2025, notamment dans l'aéronautique civile et de défense. Perspectives confirmées pour 2025, hors impact des droits de douane Chiffre D'affaires Croissance Safran Defense Aéronautique
REGULATED PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 27 days ago Safran reports first quarter 2025 revenue Safran reports 16.7% revenue growth in Q1 2025, reaching €7,257 million. Strong momentum in civil aerospace and defense sectors. FY 2025 outlook confirmed, excluding potential impact of tariffs Safran Revenue Growth Defense Q1 2025 Civil Aerospace
PRESS RELEASE published on 04/25/2025 at 06:30, 8 months 27 days ago Good start to the year Holcim Group Services Ltd reports stable net sales of CHF 5,544 million in Q1 2025, with over-proportional recurring EBIT growth and M&A momentum. Amrize spin-off on track for June 2025 listing. Full-year guidance confirmed Net Sales Holcim Recurring EBIT Amrize Spin-off M&A Momentum
PRESS RELEASE published on 04/25/2025 at 02:05, 8 months 27 days ago Kidoz Inc. : 2024 Record Adjusted EBITDA of USD $1,134,503 (CAD $1,554,963) and Revenue of USD $14,004,527 (CAD $19,194,773) Kidoz Inc. announces audited financial results for 2024, showcasing increased revenue and net income. CEO Jason Williams highlights importance of privacy-first technology in driving growth Revenue Net Income Kidoz Inc. Audited Financial Results Privacy-first Technology
PRESS RELEASE published on 04/25/2025 at 00:00, 8 months 27 days ago Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
Published on 01/22/2026 at 13:15, 10 minutes ago Kootenay Silver Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$10.0 Million
Published on 01/22/2026 at 13:15, 10 minutes ago Avino Meets Full Year 2025 Production Guidance; La Preciosa Contributes to Results
Published on 01/22/2026 at 13:05, 20 minutes ago Faraday Copper Intersects Near-Surface Copper Mineralization from Five Drill Holes in the American Eagle Area
Published on 01/22/2026 at 13:00, 25 minutes ago ATHA Energy Announces Upsizing of Convertible Debenture Financing to USD$25 Million
Published on 01/22/2026 at 13:00, 25 minutes ago Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
Published on 01/22/2026 at 13:00, 25 minutes ago vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO’s Forward-Looking Vision for Environmentally Friendly Oral Health
Published on 01/22/2026 at 12:23, 1 hour 2 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 01/22/2026 at 12:20, 1 hour 5 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 01/22/2026 at 11:45, 1 hour 40 minutes ago TradeInn Scales Global Operations: A Tech-Driven Powerhouse Reaching €585M in 2025
Published on 01/22/2026 at 08:45, 4 hours 40 minutes ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:45, 4 hours 40 minutes ago La démarche proactive d’approvisionnement en électricité bas carbone d’Air Liquide prend de l’ampleur, avec 3 TWh par an de PPA supplémentaires démarrés en 2025
Published on 01/22/2026 at 08:29, 4 hours 56 minutes ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
Published on 01/22/2026 at 07:00, 6 hours 25 minutes ago 2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Published on 01/22/2026 at 07:00, 6 hours 25 minutes ago Chiffre d'affaires 2025 : 918 M€ à devises constantes (+4.3%) - 899 M€ à devises courantes (+2.1%)